IEBH News

Professorial lecture to celebrate a remarkable career

Dr Paul Glasziou will share insights from his distinguished career in medicine at a special event before his retirement.

$2.9m grant to fight over-treatment

Bond University researcher Tammy Hoffmann OAM has received an almost $3 million grant aimed at empowering patients to have a greater say in their medical care and combating over-treatment.

Antibiotic resistance research to continue after huge funding boost

Bond University academics are among a team of researchers awarded almost $4 million to reduce the overprescription of antibiotics for common conditions such as sore throat, sinusitis and colds.

Pass the potassium and shake up your health

Bond University researchers find replacing regular salt with a salt substitute decreases the risk of death from cardiovascular disease by about 17 percent.

Evidence of overdiagnosis of non-cancer conditions

Overdiagnosis of conditions other than cancer is occurring, and researchers now have a way of estimating it.

Trending degrees for 2024

Bond University’s most popular courses for 2024 indicate students may be reacting to future job trends, with four of the top seven degrees related to the care industry.

IEBH Newsletter 2, 2023

Welcome to the Institute's final newsletter for 2023. Dive into a year of incredible achievements with us as we celebrate our impact, awards, and global recognition, upcoming events and an array of ne

Global recognition for Bond researchers

Bond University’s Professor Paul Glasziou has been named among the top 1 percent of researchers worldwide.

Professor Tammy Hoffmann takes top honour at research awards

The Vice Chancellor's Research Awards 2023 highlights recognition of traditional Indigenous knowledge as a step towards reconciliation.

Celebrating Indigenous elders' teaching legacy

NAIDOC Week kicks off at Bond University.

IEBH Newsletter: December 2022

Too much or not enough: the healthcare dilemma

Globalisation has significantly improved access to quality healthcare but some patients in developing countries are getting too much of it.